Australia markets open in 6 hours 37 minutes

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7800-0.0200 (-0.71%)
At close: 04:00PM EDT
2.8100 +0.03 (+1.08%)
After hours: 06:33PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
14,125
16,743
13,284
15,419
Cost of revenue
48,949
69,721
84,818
102,640
Gross profit
-34,824
-52,978
-71,534
-87,221
Operating expenses
Research development
129,082
159,120
90,852
50,717
Selling general and administrative
103,684
106,657
78,703
85,385
Total operating expenses
232,312
265,777
169,555
136,102
Operating income or loss
-267,136
-318,755
-241,089
-223,323
Interest expense
26,634
14,705
10,960
2,943
Total other income/expenses net
-71,166
-28,338
-10,686
-15,450
Income before tax
-364,874
-361,734
-262,243
-236,795
Income tax expense
44
51
-49
8
Income from continuing operations
-364,918
-361,785
-262,194
-236,803
Net income
-364,918
-361,785
-262,194
-236,803
Net income available to common shareholders
-364,918
-361,785
-262,194
-236,803
Basic EPS
-
-4.87
-2.68
-2.42
Diluted EPS
-
-4.89
-2.68
-2.42
Basic average shares
-
74,227
97,941
97,941
Diluted average shares
-
74,306
97,941
97,941
EBITDA
-
-326,334
-232,576
-218,653